Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) stock analysis
RARE · Ultragenyx Pharmaceutical Inc. - Common Stock
Latest recorded price: USD 15.90
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth 22.8%, free cash flow margin -70.1%. The model flags 1 risk signal for this company (1 high severity).
Similar companies in Healthcare
- Arcus Biosciences, Inc. (RCUS)
- Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)
- Relay Therapeutics, Inc. (RLAY)
- Roivant Sciences Ltd. (ROIV)
- Royalty Pharma plc (RPRX)
- Revolution Medicines, Inc. (RVMD)
- Recursion Pharmaceuticals, Inc. - Class A Common Stock (RXRX)
- Rhythm Pharmaceuticals, Inc. - Common Stock (RYTM)